Exencial Wealth Advisors, LLC Novartis Ag Transaction History

Exencial Wealth Advisors, LLC

  • $2.72 Billion
  • Q3 2024

A detailed history of Exencial Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 127,144 shares of NVS stock, worth $13.3 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
127,144
Previous 131,888 3.6%
Holding current value
$13.3 Million
Previous $14 Million 4.16%
% of portfolio
0.54%
Previous 0.54%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
SELL
$106.13 - $120.89 $503,480 - $573,502
-4,744 Reduced 3.6%
127,144 $14.6 Million
Q2 2024

Aug 12, 2024
SELL
$92.57 - $107.37 $852,477 - $988,770
-9,209 Reduced 6.53%
131,888 $14 Million
Q1 2024

May 10, 2024
SELL
$95.27 - $108.47 $280,951 - $319,878
-2,949 Reduced 2.05%
141,097 $13.6 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $547,345 - $602,335
-5,932 Reduced 3.96%
144,046 $14.5 Million
Q3 2023

Nov 08, 2023
SELL
$94.73 - $105.13 $556,444 - $617,533
-5,874 Reduced 3.77%
149,978 $15.3 Million
Q2 2023

Aug 10, 2023
SELL
$92.52 - $104.91 $1.17 Million - $1.33 Million
-12,683 Reduced 7.53%
155,852 $15.7 Million
Q1 2023

May 02, 2023
SELL
$80.03 - $92.81 $561,490 - $651,154
-7,016 Reduced 4.0%
168,535 $15.5 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $203,002 - $248,601
-2,687 Reduced 1.51%
175,551 $15.9 Million
Q3 2022

Nov 08, 2022
BUY
$74.61 - $87.26 $1.49 Million - $1.74 Million
19,925 Added 12.59%
178,238 $13.5 Million
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $169,897 - $197,812
-2,110 Reduced 1.32%
158,313 $13.4 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $1.61 Million - $1.82 Million
-20,076 Reduced 11.12%
160,423 $14.1 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $8.39 Million - $9.28 Million
-105,268 Reduced 36.84%
180,499 $15.8 Million
Q3 2021

Nov 04, 2021
BUY
$81.78 - $95.14 $6.51 Million - $7.57 Million
79,616 Added 38.62%
285,767 $23.4 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $1.33 Million - $1.46 Million
-15,545 Reduced 7.01%
206,151 $18.8 Million
Q1 2021

May 06, 2021
BUY
$83.5 - $98.47 $1.82 Million - $2.15 Million
21,842 Added 10.93%
221,696 $19 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $2.54 Million - $3.07 Million
-32,517 Reduced 13.99%
199,854 $18.9 Million
Q3 2020

Nov 13, 2020
BUY
$82.14 - $91.0 $887,522 - $983,255
10,805 Added 4.88%
232,371 $20.2 Million
Q2 2020

Aug 17, 2020
BUY
$80.93 - $91.1 $328,333 - $369,592
4,057 Added 1.87%
221,566 $19.4 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $623,592 - $873,664
8,824 Added 4.23%
217,509 $17.9 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $1.71 Million - $1.93 Million
20,243 Added 10.74%
208,685 $19.8 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $2.31 Million - $2.55 Million
27,013 Added 16.73%
188,442 $16.4 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $29,783 - $36,656
-395 Reduced 0.24%
161,429 $14.7 Million
Q1 2019

May 08, 2019
SELL
$75.32 - $86.15 $2.73 Million - $3.12 Million
-36,232 Reduced 18.29%
161,824 $15.6 Million
Q4 2018

Feb 06, 2019
SELL
$73.66 - $82.02 $204,038 - $227,195
-2,770 Reduced 1.38%
198,056 $17 Million
Q3 2018

Nov 05, 2018
SELL
$66.94 - $77.43 $233,085 - $269,611
-3,482 Reduced 1.7%
200,826 $17.3 Million
Q2 2018

Aug 01, 2018
BUY
$64.91 - $73.36 $545,568 - $616,590
8,405 Added 4.29%
204,308 $15.4 Million
Q1 2018

May 09, 2018
SELL
$70.39 - $84.15 $15,415 - $18,428
-219 Reduced 0.11%
195,903 $15.8 Million
Q4 2017

Feb 09, 2018
BUY
$72.33 - $77.64 $1.44 Million - $1.54 Million
19,868 Added 11.27%
196,122 $16.5 Million
Q3 2017

Nov 08, 2017
BUY
$74.14 - $77.27 $13.1 Million - $13.6 Million
176,254
176,254 $15.1 Million

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Exencial Wealth Advisors, LLC Portfolio

Follow Exencial Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email